FdaApplication
BLA 761148
Identifiers
- fda_app_no: BLA761148
Properties
| Property | Value |
|---|---|
| applicant_name | Assertio Specialty Pharmaceuticals, LLC |
| application_type | BLA |
| approval_date | 2022-09-09 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ROLVEDON | EFLAPEGRASTIM-XNST | 13.2MG/0.6ML | Injection |
1 product